Expertise - Page 2 of 5 Posts on Medivizor
Navigation Menu

Expertise Posts on Medivizor

Ask the Expert: Any Updates on the Use of the New Immuno-Drugs for Maintenance in Myeloma?

Ask the Expert: Any Updates on the Use of the New Immuno-Drugs for Maintenance in Myeloma?

Posted by on Dec 8, 2017 in Multiple Myeloma | 0 comments

Video information: After receiving a successful treatment, it’s recommended that patients turn to maintenance therapy to help safeguard their quality of life and help control the residual myeloma cells from developing. The landscape for maintenance therapy continues to expand as the potential effects of new immuno-drugs emerge. Listen in as...

Read More

Inside the First FDA-Approved CAR-T Cell Therapy

Posted by on Nov 8, 2017 in Leukemia | 0 comments

Video Information: The first CAR T-cell therapy to receive FDA approval, CTL019 (Kymriah) was recently approved for children and young adults with B-cell acute lymphoblastic leukemia (ALL) that is refractory or has relapsed at least twice. Expert Dr. Michael Deinginger joins Patient Power Founder Andrew Schorr to explain CAR T-cell...

Read More

Myeloma Update From ASCO 2017

Myeloma Update From ASCO 2017

Posted by on Oct 7, 2017 in Multiple Myeloma | 0 comments

Video information: On location at the recent 2017 American Society of Clinical Oncology meeting (ASCO), Dr. Hearn Jay Cho of Mount Sinai Hospital discusses news out of ASCO 2017 and what it means for myeloma patients and care partners. Dr. Cho highlights news out of the meeting, including how experts are manipulating the immune system, precision...

Read More

Inhibitor Therapies: How Do They Treat CLL?

Posted by on Oct 7, 2017 in Leukemia | 0 comments

Video information: Treatments that inhibit CLL, such as BTK Inhibitors, are becoming more commonly used in patients. So, how do they work? CLL expert Dr. John Burke explains the mechanism of action that inhibitor therapies use to treat CLL. Dr. Burke also discusses how inhibitors affect cancer proteins and how they differ from...

Read More

Is chemoradiation with local removal, better than total surgical removal to treat stage II rectal cancer?

Is chemoradiation with local removal, better than total surgical removal to treat stage II rectal cancer?

Posted by on Sep 29, 2017 in Colorectal cancer | 0 comments

In a nutshell This study looked survival rates of stage II rectal cancer patients who underwent different treatments. It compared radical surgery versus local excision with added-on chemoradiation. The article concluded that overall survival was not different between the treatments. Some background Radical surgery (RS – complete...

Read More